The TSH‐CAR‐T cells demonstrate effective antitumor activity against TSHR‐positive differentiated thyroid cancer (DTC) cell lines in vitro, accompanied by cytokine release (IFNγ, IL‐2) and robust proliferation. The gene discussed is IL2; the disease is thyroid cancer.